Analysis of the Evolution of Mortality in an Intensive Care Unit
Launched by HOSPITAL UNIVERSITARIO GETAFE · Feb 20, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how patient outcomes, specifically mortality rates, have changed over time for individuals admitted to an intensive care unit (ICU). The researchers want to examine data from an 18-bed medical-surgical ICU starting from 1991 and continuing through 2026. By analyzing this information, they aim to better understand the effectiveness of different treatment approaches, particularly for critically ill patients who often require advanced medical care and technology.
Anyone who has been admitted to the ICU may be eligible to participate in this study, as there are no specific exclusions. Participants can expect their health data to be reviewed as part of this research, which could help improve care for future ICU patients. This trial is currently recruiting, and it highlights the importance of understanding how ICU practices have evolved to enhance patient recovery and survival rates over the years.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Patients admitted to intensive care unit
- Exclusion Criteria:
- • • None
About Hospital Universitario Getafe
Hospital Universitario Getafe is a leading healthcare institution located in Getafe, Spain, dedicated to providing high-quality medical services and advancing clinical research. As a clinical trial sponsor, the hospital emphasizes innovation and scientific rigor in its research initiatives, aiming to improve patient outcomes through the development of novel therapeutic approaches. With a multidisciplinary team of experienced healthcare professionals and researchers, Hospital Universitario Getafe is committed to fostering collaboration and integrating cutting-edge technology in its clinical trials, ensuring ethical standards and adherence to regulatory guidelines.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Getafe, Madrid, Spain
Patients applied
Trial Officials
Fernando Frutos-Vivar, MD
Principal Investigator
Hospital Universitario de Getafe
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials